Common Stock, Shares, Outstanding of Genprex, Inc. from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Genprex, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • Genprex, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 1,004,247, a 82% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Genprex, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 1,004,247 -4,484,905 -82% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 33,145,048 +30,589,313 +1197% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 24,154,348 +22,231,762 +1156% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 217,234 -1,268,668 -85% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 5,489,152 -53,940,670 -91% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 2,555,735 -49,423,343 -95% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 1,922,586 -50,051,492 -96% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 1,485,902 +283,225 +24% 31 Dec 2023 10-K 01 Apr 2025 2024 FY
Q3 2023 59,429,822 +11,409,498 +24% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 51,979,078 +4,080,727 +8.5% 30 Jun 2023 10-Q 21 Aug 2023 2023 Q2
Q1 2023 51,974,078 +4,094,370 +8.6% 31 Mar 2023 10-Q 22 May 2023 2023 Q1
Q4 2022 1,202,677 -46,672,031 -97% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 48,020,324 +216,754 +0.45% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 47,898,351 +375,494 +0.79% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 47,879,708 +564,888 +1.2% 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 47,874,708 +4,757,027 +11% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 47,803,570 +8,339,848 +21% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 47,522,857 +8,893,628 +23% 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 47,314,820 +14,464,979 +44% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 43,117,681 +23,853,840 +124% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 39,463,722 +23,620,867 +149% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 38,629,229 +22,826,374 +144% 30 Jun 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 32,849,841 +17,289,076 +111% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 19,263,841 +4,024,693 +26% 31 Dec 2019 10-K 26 Mar 2021 2020 FY
Q3 2019 15,842,855 +770,296 +5.1% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 15,802,855 +1,905,929 +14% 30 Jun 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 15,560,765 +3,805,761 +32% 31 Mar 2019 10-Q/A 20 May 2019 2019 Q1
Q4 2018 15,239,148 +3,517,564 +30% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 15,072,559 +14,718,883 +4162% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 13,896,926 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 11,755,004 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 11,721,584 +357,417 +3.1% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 353,676 30 Sep 2017 10-Q 05 Dec 2017 2017 Q3
Q4 2016 11,364,167 31 Dec 2016 10-K 17 Apr 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.